List of Imaging Companies in California - 38

Over the past decade, Advanced Brain Monitoring has developed and implemented mobile, user-friendly platforms for acquiring, integrating, analyzing and reporting multi-sensor data in real-world applications. Our strong and growing technical team includes PhD- and masters-level hardware engineers, biostatisticians, software engineers and experts in signal processing, experimental design and clinical trials. ABM seeks to build on existing collaborations within the academic community and develop strategic partnerships across industry with like-minded professionals.

We are dedicated to transforming lives by improving the journey to a healthy, beautiful smile. Discover your straight path to a bright future at Align Technology. As a part of our smart, diverse and fast-moving global team, you'll make an impact on the market leader that's moving an industry forward. Want to find out what's next for us—and for you? Follow us on LinkedIn for business updates and check out our current opportunities at www.aligntech.com/careers. 25 years ago, we pioneered the market for clear aligners. Since then, we have continuously innovated with new products and technologies that revolutionize treatments for doctors and their patients. Today, doctors and labs in over 100 markets use the Invisalign system, iTero intraoral scanners and exocad software to improve smiles for patients – from simple tooth alignment to complex corrections, kids to adults, orthodontics to multi-disciplinary restorative treatment. Learn more about Align Technology and our products: www.aligntech.com www.invisalign.com www.itero.com www.exocad.com

Avinger, Inc. is a commercial-stage medical device company that designs, manufactures and sells image-guided, catheter-based systems for the treatment of patients with peripheral artery disease (PAD). PAD is characterized by a build-up of plaque in the arteries that supply blood to the arms and legs. The company’s mission is to radically change the way vascular disease is treated through the introduction of products based on its lumivascular platform, the only intravascular image-guided system of therapeutic catheters available in this market. Avinger’s current lumivascular products include the Lightbox imaging console, the Ocelot family of catheters, which are designed to penetrate total arterial blockages, known as chronic total occlusions, or CTOs, and Pantheris, the first-ever image- guided atherectomy device, designed to precisely remove arterial plaque in PAD patients.

CapsoVision is a medical device manufacturer based in Silicon Valley, USA. We are engaged in the development of innovative capsule endoscopy (CE) solutions that empower physicians, streamline clinical operations and enhance patient experience. Our novel small bowel capsule endoscope CapsoCam Plus® is the only CE system with a 360° field of view, no capital equipment, and a state-of-the-art CapsoCloud® cloud-based software for efficient image review and analysis.

Darmiyan is a pioneering brain technology (deep-tech) company based in San Francisco, California, focused on developing innovative and rapidly scalable products for brain health screening and monitoring. The company's mission is to enhance brain health, equipping physicians with tools for precise, personalized patient care, thereby optimizing health outcomes. Darmiyan's first product, BrainSee, is FDA-approved and available to physicians to aid in prognosis of patients diagnosed with amnestic mild cognitive impairment (aMCI).

Edan is a healthcare company dedicated to improving the human condition around the world by delivering value-driven, innovative and high-quality medical products and services. For over 20 years, Edan has been pioneering a comprehensive line of medical solutions that address a broad range of healthcare practices including Diagnostic ECG, OB/GYN, Ultrasound Imaging, In-Vitro Diagnostics, Patient Monitoring, Point-of-Care Testing, and Veterinary. Healthcare professionals around the world depend on Edan's breakthrough medical technologies and outstanding customer support. Till now, EDAN has reached over 170 countries and areas and 40,000 medical facilities with Industry Leading Healthcare solutions.

Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery. They are pioneering a new method of drug discovery based on tracking and measuring movement of molecules within living cells. The company leverages superior engineering and high-performance computing to analyze single molecules and discover innovative medicines.

Gynesonics is a medical technology company that specializes in providing minimally invasive solutions for women's health, particularly in the treatment of uterine fibroids.

Vista.ai is harnessing the power of artificial intelligence (AI) to offer clinicians an easy, cost-effective and stress-free way to conduct MRI studies. The company's FDA 510(k) cleared MRI CoPilot™ software-only solution automates and dramatically simplifies a CMR exam, enabling any MRI tech to perform a CMR in a standard mixed-use scanner time slot. Available for use on Siemens Healthineers and GE Healthcare MRI scanners, MRI CoPilot™ • Eliminates the need for specialized CMR technologist • Allows CMRs to fit into your mixed-use scanner standard time slot • Makes scans less stressful for the technologist • Gives patients greater comfort and convenience Vista.ai is funded by Khosla Ventures, and the National Institute of Health's Small Business Innovation Research program.

Enhance Productivity and Quality with Reporting Automation and Ultrasound Reading Tools Imorgon provides innovative solutions for Radiology reporting automation and ultrasound reading. Our tools dramatically improve the efficiency and quality of creating structured reports. Ultrasound Reporting Software: Measurement Transfer: Our tools extract measurements from various imaging modalities, including ultrasound, CT, and DEXA, from DICOM SR and other structured files. These measurements are parsed and seamlessly inserted into a reporting package, enabling the creation of structured reports more efficiently and with higher precision. Electronic Worksheets: Imorgon offers customizable electronic worksheets that allow technologists to capture exam findings consistently and quickly. These findings can be automatically integrated into the report, eliminating the need for a Radiologist to dictate them. This approach is superior to traditional solutions that store worksheet images in PACS and require Radiologist re-entry. Together, DICOM SR and electronic worksheets form a comprehensive ultrasound reporting solution. Ultrasound Reading and PACS: Many PACS viewing stations provide an inflexible and suboptimal exam review experience. Imorgon addresses these limitations by offering advanced features. Our platform enables the display of ultrasound images and clips in interleaved, acquisition order with automatic clip playing. Additionally, our Sonographer QC Workstation empowers sonographers to correct patient and study information, split or merge studies, delete images, add or edit annotations, and make measurements. These capabilities enhance efficiency and accuracy in ultrasound reading. Integration: Imorgon seamlessly integrates with enterprise PACS, HIS/RIS, and reporting systems, ensuring a smooth workflow and compatibility with existing infrastructure.

InkSpace Imaging Inc. is a medical device manufacturer that specializes in innovative magnetic resonance imaging (MRI) technology. Founded in 2017 by researchers from UC Berkeley, the company aims to enhance patient comfort and diagnostic efficiency with its lightweight and flexible MRI-receive coils. Their mission focuses on transforming MRI experiences for both healthcare providers and patients by prioritizing comfort, performance, and cost-effectiveness. The company produces featherlight, flexible MRI coils suitable for 1.5T and 3T MRI systems. Notable products include a 24-channel body array designed for pediatric patients, featuring a dinosaur-themed design to help reduce anxiety. These coils are adaptable to various body shapes and sizes, offering 360-degree coverage and positioning freedom. InkSpace's proprietary printed technology allows for low-cost manufacturing of coils that conform closely to anatomy, minimizing the need for sedation in pediatric imaging. The company also emphasizes patient-centered design and technical support to improve MRI workflows and patient throughput.

Invenio Imaging is a medical device start-up based in Santa Clara, CA dedicated to advancing the care of cancer patients by combining intraoperative histologic imaging with artificial intelligence. Our technology, the NIO® Laser Imaging System has been used in over 2500 cancer treatment procedures at major cancer centers both in the US and in Europe. In 2021 Invenio received a Medical Design Excellence Award, was selected to be a Rosenman Innovator and received CE Mark to commercialize in Europe.

The iSono Health has developed the world’s first AI-driven platform with an automated, portable, and wearable ultrasound to empower women and their physicians with early breast cancer detection and monitoring. Our patented compact ultrasound scanner captures 3D images by automatically scanning the whole breast volume in 2 minutes. The device connects to a smartphone/tablet/laptop. The data is transferred to a secure cloud for image processing and storage. Our machine-learning algorithm uses acoustic biomarkers to identify abnormal masses. Our platform’s automated operation and software expand ultrasound use in point-of-care diagnostics and monitoring of breast health at radiology centers, walk-in, and mobile clinics. iSono Health offers women and healthcare providers : Safety: No Radiation Actionable Feedback with AI Fast: 2min Scan Easy to Use

Laza Medical is a healthcare technology company based in California, founded in 2020. As a portfolio company of Shifamed, it focuses on developing innovative solutions for cardiovascular interventions. The company specializes in AI-powered robotic assistance technology, which enhances medical imaging and procedures. Laza Medical's main offering is an advanced imaging solution that supports cardiovascular interventions. This solution utilizes AI and robotic technology to provide navigation tools for structural heart and electrophysiology procedures in cath labs. The company aims to improve the precision and efficiency of these medical procedures through its technology. In December 2023, Laza Medical raised $36 million in a Series A funding round, led by The Capital Partnership, with participation from investors like Unorthodox Ventures and GE Healthcare Financial Services. With its innovative approach and strong funding support, Laza Medical is positioned to make a notable impact in the medical technology field.

Meditrina is an innovative start up Company located in San Jose, CA, and founded in 2016 developed the Aveta™ hysteroscopy suite which was designed to provide physicians with the best care in their diagnosis and treatment of endometrial polyps and uterine fibroids. The system seamlessly integrates into any operating, procedure, or exam room. This new hysteroscopy system is an all-in-one platform which includes the single-use Aveta™ Pearl Hysteroscope for myomectomy, and the single-use Aveta™ Coral Hysteroscope for polypectomy procedures with integrated tissue resection and fluid management capability. The Aveta™ Pearl Hysteroscope is the first single-use hysteroscope to include full physician control providing proprietary fluid management and video control function directly on the hysteroscope handle.

NeuraSignal is a medical technology company based in California that specializes in advanced cerebral blood flow assessment. The company focuses on non-invasive solutions for neurological conditions such as stroke, traumatic brain injury, and dementia. NeuraSignal employs robotics, artificial intelligence, and cloud-based analytics to enhance patient care and improve clinical outcomes. The flagship product, NovaGuide Intelligent Ultrasound, is an FDA-cleared robotic transcranial Doppler system. It features innovations like Automated Depth Walk for precise data collection, Multi-Vessel Search for efficient assessments, and Automated Snapshots to capture critical data points quickly. NeuraSignal also offers a cloud-connected platform that allows healthcare providers to access data remotely, stream live exams, and collaborate effectively, supporting real-time decision-making. NeuraSignal serves healthcare providers in neurology, critical care, and emergency medicine, focusing on those managing complex neurological conditions. The company is committed to adhering to regulatory standards to ensure the safety and efficacy of its solutions.

Noah Medical is a medical technology company based in San Carlos, California, founded in 2018. The company specializes in developing advanced medical robotics aimed at enhancing diagnostic procedures in pulmonology. Its flagship product, the Galaxy System, is a robotic platform that integrates real-time navigation, augmented fluoroscopy, and tomosynthesis to improve the accuracy of lesion localization, which is vital for early lung cancer diagnosis and treatment. With a team of over 150 engineers and industry experts, Noah Medical leverages extensive experience from leading healthcare companies. The company's mission focuses on saving lives through early diagnosis and treatment, particularly in robotic navigated bronchoscopy. Noah Medical has received recognition as a "Fierce 15" company of 2023 and has raised $150 million in funding to support its innovative approach. Its technology is designed to enhance procedural efficiency and diagnostic accuracy in healthcare facilities, particularly in pulmonology and oncology.

Ocutrx Technologies, Inc. is a high-tech company that specializes in augmented reality (AR), extended reality (XR), and 3D visualization technologies. They develop innovative solutions for various sectors, including medical, military, consumer, and enterprise applications. Ocutrx aims to enhance how users interact with visual data, focusing on improving situational awareness and accessibility for visually impaired individuals. The company offers several products, including the OcuLenz AR/XR headset, which assists patients with advanced macular degeneration and is also suitable for gaming and telemedicine. Their ORLenz system enhances surgical visualization, allowing surgeons to interact more effectively with patient data. Ocutrx also provides customizable AR/XR platforms for developers and enterprises, promoting productivity and immersive experiences. Ocutrx serves a diverse range of customers, including healthcare professionals, military personnel, and developers creating AR/XR applications. The company holds over 25 patents related to AR/XR innovations, particularly in healthcare, showcasing their commitment to advancing technology in this field.

OD-OS aims to set new standards of care for retina treatment. By extending our innovative Retina Navigation platform, our goal is to become the global leader in novel therapeutic solutions for the growing number of people suffering from retina diseases. Join the Navilas mailing list: https://tinyurl.com/od-os-mailing-list Follow us on Twitter: https://twitter.com/OD_OS_Navilas Privacy Policy Social Media Pages: https://www.od-os.com/legal-notice-container/privacy-policy/social-media

Onc.AI is venture-capital backed company committed to developing robust, clinically validated, imaging-AI powered clinical management solutions focused on immunotherapy optimization. Using patented, radiomic-based AI models, Onc.AI has developed a clinical decision support platform using routine diagnostic imaging scans specifically for planning and guidance of first-line immune checkpoint inhibitors (ICI) treatment plans.

Visionix is the global manufacturer and exclusive sales, service and training provider for Optovue OCT, Visionix screening and refraction systems, as well as Briot and Weco lens finishing equipment in North America. We are the pioneer in integrating core refractive, screening, and imaging technologies to address the ever-changing needs of eye care professionals in this dynamic market. Today, we are proud to offer high-speed OCT and OCT-A technology designed to facilitate diagnosing and managing a range of ocular diseases. Our goal is to improve access to a complete suite of advanced visual health solutions that transforms the patient experience. With over 100 years of innovation, an expanded product line, as well as a new level of support, clinical education, and practice integration, we are well-positioned to help you unlock your potential. *Not all products, services, or offers are available in every market, and approved labeling and instructions may vary from one country to another.

As a global leader in digital pathology, OptraSCAN is dedicated to revolutionizing diagnostics and patient care through advanced technology. We specialize in providing cutting-edge digital pathology solutions, including state-of-the-art digital pathology scanners and whole slide imaging scanners, designed to enhance the accuracy and efficiency of diagnostic processes. Our extensive range of digital slide scanners includes brightfield slide scanners, histology slide scanners, and fluorescence slide scanners, enabling healthcare institutions to transition seamlessly from traditional microscopy to sophisticated digital pathology systems. Our whole slide scanners and digital pathology slide scanners offer high-resolution imaging that improves precision, streamlines workflows, and provides cost-effective results. OptraSCAN leads the way in digital histopathology with innovative solutions that integrate advanced artificial intelligence (AI). Our AI-powered pathology scanners and digital pathology artificial intelligence technologies are designed to boost diagnostic accuracy and efficiency. We offer comprehensive solutions including whole slide imaging scanners and computer-aided region detection systems. We are committed to making digital pathology accessible to all, providing compact and advanced scanning systems that overcome barriers to modern diagnostic methods. Our digital pathology solutions include cloud-based LIMS (CLOUDPath), image analysis tools (OptraASSAYS), and up to 10 TB of complimentary cloud storage. By choosing OptraSCAN, you partner with a leading digital pathology company that is shaping the future of diagnostics with high-quality digital pathology scanners and integrated whole slide imaging solutions. Our goal is to ensure that healthcare systems worldwide can seamlessly adopt and benefit from our transformative digital pathology technologies.

PROCEPT BioRobotics is a medical robotics company that specializes in minimally invasive robotic surgery technology.

Promaxo is a medical technology company that develops and commercializes customer-centric MRI systems and MRI based technologies that enhance patients' experiences and outcomes. The Promaxo MRI system is designed for image-guided interventions including live MRI guided biopsies, treatment planning, robotic surgeries, and radiation.

The QTI team has been on an incredible journey, starting with a shared mission to create disruptive innovation to expand access to medical imaging while ensuring superior patient experience and improving health outcomes. We anchor our efforts in medical imaging because when the body can be scanned often and without harm, health conditions can be detected before symptoms appear. Chief among the new advancements in medical imaging is 3D body imaging. Today QTI focuses on our breast imaging technology, which is native 3D, high resolution, and generates reproducible image quality regardless of operator or breast size or tissue type. Current breast imaging paradigm leads to unnecessary concern and cost. ▪️Unlike mammography, QTI technology is effective in screening women with dense breasts, or 40% of women in US. ▪️35% of women aged 40-70 do not get screened. Of the 65% of women who get screened, 15% suffer unnecessary callbacks for ultrasounds, MRI, or biopsies. 80% of biopsies are benign. ▪️QTI’s technology can be a much-needed alternative for high risk women under 40, as cancers in younger women are usually aggressive and survival outcomes are poor. Our QT Imaging Breast Acoustic CT™ Scanner is the only true 3D imaging device, FDA cleared for use as a transmission and reflection low frequency soundwaves imaging system for a patient’s breast. There is no ionizing radiation or compression like in mammography or contrast dyes injections like in MRIs. The technology uniquely quantifies breast density. Surface-to-volume ratios and volumetric doubling time growth rate can be calculated to determine significance of lesions and improve specificity. This breast scanning system gives women the choice they deserve to ensure their breast health over time; for healthcare providers, a technology that is accessible, affordable, and accurately visualizes internal structures of the breast; and, for investors, a market segment extension and a purposeful investment opportunity.

RapidAI is the global leader in using AI to combat life-threatening vascular and neurovascular conditions. Leading the next evolution of clinical decision-making and patient workflow, RapidAI is empowering physicians to make faster decisions for better patient outcomes. Based on intelligence gained from over 10 million scans in more than 2,000 hospitals in over 100 countries, the Rapid® platform transforms care coordination, offering care teams a level of patient visibility never before possible. RapidAI — where AI meets patient care.

The company uses biology-guided radiotherapy to detect and respond to signals emitted from cancer cells, and use them to guide treatment.

Sanovas, Inc. is a life science asset holding company that is developing and accelerating companies that create medical technologies which are advancing the next generation of minimally invasive surgical tools and technologies.

Siemens Healthineersenables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare.COVID-19: CE mark for its molecular Fast Track Diagnostics (FTD)SARS-CoV-2 Assay.

Spectrum Dynamics is spearheading the transformation of Nuclear Medicine from analog to digital technology, enabling clinicians to provide superior healthcare services with improved image quality and efficiency at lower doses. D-SPECT®: The world's first digital cardiac SPECT system based on Broadview Technology: swiveling CZT digital detectors. It is the platform for advanced applications such as TruCorr Attenuation Correction, TruFlow 3D dynamic SPECT imaging for Myocardial Flow Reserve (MFR) analysis, Simultaneous Dual Isotope Imaging (SDI). TruCorr: a deep learning application to generate attenuation corrected myocardial perfusion images. There is no need for additional CT transmission scan, as TruCorr utilizes the SPECT scan emission data. VERITON-CT®: The world's first digital 360°CZT-based, ring-shaped gantry design SPECT/CT, with high-resolution 16 or 64 slice CT. It’s 80cm wide bore accommodates patients of all sizes. VERITON features TruFlow 3D dynamic SPECT/CT imaging for SPECT MFR, bone, renal, and general studies. VERITON-CT continues to evolve with an energy range up to 400 KeV and multiple peak imaging, providing highest quality and quantitation-ready images.

Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 150 million patients annually. More information is available at stryker.com and careers.stryker.com. Facts: ● 2023 Sales: $20.5 billion ● Industry: Medical Instruments & Supplies ● Employees: 52,000 worldwide ● 40 years of sales growth leading up to 2020 ● 44+ Manufacturing and R&D Locations Worldwide ● $1.4 billion spent on research and development in 2023 ● ~12,900 patents owned globally in 2023 ● Products sold in ~75 countries ● Fortune 500 Company ● 7 consecutive years as one of Fortune's World's Best Workplaces Stryker’s social media community guidelines: https://www.stryker.com/content/m/legal/social-media-community-guidelines/en/index.html Notice Regarding Employee Conduct on Facebook/LinkedIn Meta/LinkedIn does not permit employers to verify or validate “employees” in the (META: “Works at” LinkedIn: “Experience”) section of users’ profiles. Please be aware that the views expressed by individuals on their personal accounts and do not necessarily represent the views of our company. If you encounter any issues with a person claiming to be our employee, we recommend using the “Report Profile” feature. If you’d like to report concerns to our Ethics Hotline, you may do so at: https://app.convercent.com/en-us/LandingPage/b6bb4e84-9fcb-ea11-a974-000d3ab9f296

Subtle, Inc., is a medical imaging software company. Our goal is to improve the quality, value, and accessibility of medical imaging by significantly reducing cost, imaging time, and radiation dose. We use the state-of-art proprietary deep learning AI algorithms to renovate the radiology workflow to deliver faster, safer and smarter solutions for imaging exams.

TTI Medical specializes in video and digital camera adaptation onto surgical microscopes, ophthalmic slit lamps, and endoscopes. In addition, we are a distributor of Ikegami and Sony medical video cameras. We also manufacture various CO₂ laser accessories, fiberoptic handpieces, and re-usable suction/irrigation instruments. TTI Medical was established in 1984 with the mission of designing and marketing high quality, technologically advanced surgical instruments and medical devices. Our product design criteria must pass critical tests for performance, convenience, dependability, and cost containment. Product quality is held to the highest standards. Opportunities within the medical marketplace are constantly being identified and evaluated for new product development. Patents protect the proprietary technology utilized in the ACCU-Beam® and ACCU-Surg® product lines. The fundamental principal of “universality” is incorporated in each product design. Universality ensures the end user of maximum utilization at the lowest possible cost. Our philosophy of producing high quality reusable surgical devices focuses on the cost containment criteria required within the hospital managed care environment. Our quality policy is to provide products that satisfy the requirements of our customers including regulatory, design, and cost specifications. Products shall be produced under a management system in compliance with quality standards of ISO 13485:2016, FDA 21CFR820, and the European Medical Device Regulation 2017/745. Our policy is to be in compliance with all regulations that apply to the products in countries where our products are distributed. Products shall only be released if they conform to specifications without functional defect.

UroViu Corporation's mission is to revolutionize the cystoscopy platform for improved patient care and efficiency and has operations in California and Washington and production facilities in Asia. UroViu is the developer of the always ready cystoscopy platform, the most portable, self-contained and versatile single-use cystoscopy solution on the market. The intuitive portable platform and product suite are protected by a portfolio of 13 granted and many more pending patents. UroViu's vision is to simplify the scope of patient care.

Our mission is to be the preferred therapeutic system for patients with reduced tissue perfusion. The Company has developed the first wearable therapeutic ultrasound device for the noninvasive, outpatient treatment of peripheral arterial disease. It is designed to promote vasodilation, collateral vessel growth and angiogenesis, and restore perfusion.

At ViewRay, our vision is clear: conquer cancer by re-envisioning radiation therapy., giving doctors new and better ways to treat their patients. ViewRay®, Inc. (NASDAQ:VRAY) shifts the paradigm in cancer treatment with the MRIdian® MRI-guided adaptive radiotherapy system. We're changing radiation therapy for the better with accurate, precise and personalized cancer treatment that no other system delivers, addressing the key limitations of existing external-beam radiation therapy technologies. Real-time imaging clearly defines the targeted tumor from the surrounding soft tissue and other critical organs during radiation treatment. MRIdian shapes the dose to fit the day. It's the only MR solution that enables fully integrated adaptive treatment with complete, on-table re-optimization of the daily treatment plan. It knows when to strike – and when to stop. MRIdian is the only RT solution with automated beam gating for precise and accurate dosing. When the tumor moves, the beam stops. The result? Better outcomes for patients. After seven years of clinical use, MRIdian has treated more than 12,500 patients worldwide. We're an innovative, entrepreneurial company with big ambitions, unlimited potential and a passion for a culture that is diverse and committed to our physicians and their patients. If you're ready to change the way the world views cancer, come join our team.